120 related articles for article (PubMed ID: 2711992)
21. Comparison of equal-weight oral dosages of verapamil hydrochloride and diltiazem hydrochloride in patients with mild to moderate hypertension.
Hollifield JW; Heusner JJ; DesChamps M; Gray J; Spyker DA; Peace KE; Dickson B
Clin Pharm; 1988 Feb; 7(2):129-34. PubMed ID: 3280220
[TBL] [Abstract][Full Text] [Related]
22. A comparative study of long acting diltiazem (Tildiem LA) with sustained release nifedipine (nifedipine SR) and bendrofluazide in the treatment of mild to moderate hypertension.
Hosie J; Nasar MA; Belgrave GP; Walters EG
Acta Cardiol; 1994; 49(3):251-65. PubMed ID: 7941918
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of sustained-release diltiazem as replacement therapy for beta blockers and diuretics for stable angina pectoris and coexisting essential hypertension: a multicenter trial.
Kawanishi DT; Leman RB; Pratt CM; O'Rourke RA
Am J Cardiol; 1987 Dec; 60(17):29I-35I. PubMed ID: 2891291
[TBL] [Abstract][Full Text] [Related]
24. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
[TBL] [Abstract][Full Text] [Related]
25. Diuretics versus calcium-channel blockers in systemic hypertension: a preliminary multicenter experience with hydrochlorothiazide and sustained-release diltiazem.
Frishman WH; Kirkendall W; Lunn J; McCarron D; Moser M; Schnaper H; Smith LK; Sowers J; Swartz S; Zawada E
Am J Cardiol; 1985 Dec; 56(16):92H-96H. PubMed ID: 3907323
[TBL] [Abstract][Full Text] [Related]
26. 24-hour efficacy of once-daily diltiazem in essential hypertension.
Massie BM; Der E; Herman TS; Topolski P; Park GD; Stewart WH
Clin Cardiol; 1992 May; 15(5):365-8. PubMed ID: 1623657
[TBL] [Abstract][Full Text] [Related]
27. The Diltiazem Different Doses Study--a dose-response study of once-daily diltiazem therapy for hypertension.
Nilsson P; Lindholm LH; Hedner T
J Cardiovasc Pharmacol; 1996 Apr; 27(4):469-75. PubMed ID: 8847861
[TBL] [Abstract][Full Text] [Related]
28. Antihypertensive efficacy and tolerability of once-daily sustained-release diltiazem alone and in combination with ramipril in hypertension.
Tuteja R; Swarup D; Saxena GN; Bhandari S; Sharma P
J Assoc Physicians India; 1999 Oct; 47(10):962-5. PubMed ID: 10778687
[TBL] [Abstract][Full Text] [Related]
29. A dose escalation trial comparing the combination of diltiazem SR and hydrochlorothiazide with the monotherapies in patients with essential hypertension.
Weir MR; Weber MA; Punzi HA; Serfer HM; Rosenblatt S; Cady WJ
J Hum Hypertens; 1992 Apr; 6(2):133-8. PubMed ID: 1597846
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of a once daily graded-release diltiazem formulation in essential hypertension.
Glasser SP; Neutel JM; Gana TJ; Albert KS
Am J Hypertens; 2003 Jan; 16(1):51-8. PubMed ID: 12517683
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of blood pressure response to the combination of enalapril (single dose) and diltiazem ER (four different doses) in systemic hypertension.
Applegate WB; Cohen JD; Wolfson P; Davis A; Green S
Am J Cardiol; 1996 Jul; 78(1):51-5. PubMed ID: 8712118
[TBL] [Abstract][Full Text] [Related]
32. An assessment of diltiazem and hydrochlorothiazide in hypertension. Application of factorial trial design to a multicenter clinical trial of combination therapy.
Burris JF; Weir MR; Oparil S; Weber M; Cady WJ; Stewart WH
JAMA; 1990 Mar; 263(11):1507-12. PubMed ID: 2407872
[TBL] [Abstract][Full Text] [Related]
33. Clinical efficacy of force titrated doses of diltiazem extended-release. A placebo controlled study.
Lacourcière Y; Poirier L; Lefebvre J; Burford RG
Am J Hypertens; 1995 Mar; 8(3):282-6. PubMed ID: 7794578
[TBL] [Abstract][Full Text] [Related]
34. Antihypertensive efficacy and safe use of once-daily sustained-release diltiazem in the elderly: a comparison with captopril. The Dilcacomp Study Group.
Nicaise J; Neveux E; Blondin P
J Int Med Res; 1995; 23(4):244-53. PubMed ID: 7589767
[TBL] [Abstract][Full Text] [Related]
35. Multicenter evaluation of the efficacy and safety of sustained-release diltiazem hydrochloride for the treatment of hypertension.
Woehler TR; Eff J; Graney W; Heald D; Ziemniak J; Magner D
Clin Ther; 1992; 14(2):148-57. PubMed ID: 1611639
[TBL] [Abstract][Full Text] [Related]
36. Comparison of diltiazem and atenolol in young, physically active men with essential hypertension.
Myburgh DP; Gordon NF
Am J Cardiol; 1987 Nov; 60(13):1092-5. PubMed ID: 3314458
[TBL] [Abstract][Full Text] [Related]
37. Antihypertensive efficacy of twice daily controlled release diltiazem using 24 hour intra-arterial blood pressure monitoring.
Sridhara BS; Thomas P; Lahiri A; Raftery EB
Eur J Clin Pharmacol; 1994; 46(5):427-30. PubMed ID: 7957537
[TBL] [Abstract][Full Text] [Related]
38. Metabolic effects of antihypertensive therapy with a calcium antagonist.
Pool PE; Herron JM; Rosenblatt S; Reeves RL; Nappi JM; Staker LV; DiPette DJ; Evans RR
Am J Cardiol; 1988 Oct; 62(11):109G-113G. PubMed ID: 3051991
[TBL] [Abstract][Full Text] [Related]
39. A randomized, controlled trial comparing diltiazem, hydrochlorothiazide, and their combination in the therapy of essential hypertension.
Pool PE; Applegate WB; Woehler T; Sandall P; Cady WJ
Pharmacotherapy; 1993; 13(5):487-93. PubMed ID: 8247917
[TBL] [Abstract][Full Text] [Related]
40. Double-blind, parallel, comparative multicentre study of a new combination of diltiazem and hydrochlorothiazide with individual components in patients with mild or moderate hypertension.
Manning G; Joy A; Mathias CJ; McDonald CJ; Millar-Craig MW
J Hum Hypertens; 1996 Jul; 10(7):443-8. PubMed ID: 8880557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
